Michael Jay Ross - 21 Oct 2021 Form 3 Insider Report for Xilio Therapeutics, Inc. (XLO)

Role: Director
Signature: /s/ Chris Frankenfield, Attorney-in-Fact
Issuer symbol: XLO
Transactions as of: 21 Oct 2021
Transactions value $: $0
Form type: 3
Filing time: 21 Oct 2021, 20:48:15 UTC
Next filing: 17 Jun 2022
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit Index: 24.1 Power of Attorney